Propanc Biopharma Company Top Management

PPCB Stock  USD 0.0003  0.00  0.00%   
Propanc Biopharma employs about 1 people. The company is managed by 3 executives with a total tenure of roughly 3 years, averaging almost 1.0 years of service per executive, having 0.33 employees per reported executive. Analysis of Propanc Biopharma's management performance can provide insight into the company performance.
James Nathanielsz  CEO
CEO, Treasurer, Secretary, Director
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Propanc Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Propanc Biopharma Management Team Effectiveness

The company has return on total asset (ROA) of (13.0742) % which means that it has lost $13.0742 on every $100 spent on assets. This is way below average. Propanc Biopharma's management efficiency ratios could be used to measure how well Propanc Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.

Propanc Biopharma Workforce Comparison

Propanc Biopharma is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 311. Propanc Biopharma adds roughly 1.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Propanc Biopharma Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Propanc Biopharma Price Series Summation is a cross summation of Propanc Biopharma price series and its benchmark/peer.

Propanc Biopharma Notable Stakeholders

A Propanc Biopharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Propanc Biopharma often face trade-offs trying to please all of them. Propanc Biopharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Propanc Biopharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
James NathanielszCEO, Treasurer, Secretary, DirectorProfile
ChB MDCTO OfficerProfile
Pr KutzChief BoardProfile

About Propanc Biopharma Management Performance

The success or failure of an entity such as Propanc Biopharma often depends on how effective the management is. Propanc Biopharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Propanc management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Propanc management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia. Propanc Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
Please note, the presentation of Propanc Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Propanc Biopharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Propanc Biopharma's management manipulating its earnings.

Propanc Biopharma Workforce Analysis

Traditionally, organizations such as Propanc Biopharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Propanc Biopharma within its industry.

Propanc Biopharma Manpower Efficiency

Return on Propanc Biopharma Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee2.7M
Net Loss Per Executive886K

Complementary Tools for Propanc Pink Sheet analysis

When running Propanc Biopharma's price analysis, check to measure Propanc Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Propanc Biopharma is operating at the current time. Most of Propanc Biopharma's value examination focuses on studying past and present price action to predict the probability of Propanc Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Propanc Biopharma's price. Additionally, you may evaluate how the addition of Propanc Biopharma to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine